Osteoporosis in Rheumatic Diseases

Osteoporosis is a chronic disease characterized by an increased risk of fragility fracture. Patients affected by rheumatic diseases are at greater risk of developing osteoporosis. The purpose of the present review is to discuss the pathogenesis, epidemiology, and treatment of osteoporosis in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Adami, Giovanni, Fassio, Angelo, Rossini, Maurizio, Caimmi, Cristian, Giollo, Alessandro, Orsolini, Giovanni, Viapiana, Ombretta, Gatti, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928928/
https://www.ncbi.nlm.nih.gov/pubmed/31766755
http://dx.doi.org/10.3390/ijms20235867
Descripción
Sumario:Osteoporosis is a chronic disease characterized by an increased risk of fragility fracture. Patients affected by rheumatic diseases are at greater risk of developing osteoporosis. The purpose of the present review is to discuss the pathogenesis, epidemiology, and treatment of osteoporosis in patients affected by rheumatic diseases with special focus for rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, systemic lupus erythematosus, systemic sclerosis, vasculitides, Sjogren syndrome, and crystal-induced arthritis.

Ejemplares similares